In another similar study in a group with newly diagnosed AML with FLT3-ITD mutation, a high AR (>0.51) and FLT3-ITD insertion site in TKD1 were associated with low complete remission (CR) and worse prognosis [22]. The gene discussed is FLT3; the disease is acute myeloid leukemia.